Bachem Holding (Suzhou): difference between revisions
Diff·revision 41 → 42·15:03, 17 May 2025
Difference between revision 41 and revision 42 of Bachem Holding (Suzhou). 5 lines changed; the page grew by 810 bytes.
| Revision 41 — 07:15, 10 May 2025 LedgerLysander (talk) update infobox 9,113 bytes +783 | Revision 42 — 15:03, 17 May 2025 BatchNumberBede (talk) rv promotional edit 9,923 bytes +810 | ||
|---|---|---|---|
| 68 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 68 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| 69 | 69 | ||
| + | 70 | == Regulatory position and legal status == | |
| + | 71 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 72 | ||
| + | 73 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| + | 74 | ||
| 70 | == References == | 75 | == References == |
| 71 | {{reflist}} | 76 | {{reflist}} |